7.1 Gastrointestinal Disorders, Nutrition, and Hepatic Disease

7.1 Gastrointestinal Disorders, Nutrition, and Hepatic Disease

Gastrointestinal and hepatic disorders constitute a substantial proportion of acute medical-surgical admissions. These conditions range from mucosal erosions and life-threatening intra-abdominal hemorrhage to severe enzymatic autodigestion and multi-organ failure. Professional nursing practice demands rapid assessment, meticulous hemodynamic monitoring, strict adherence to specialized nutritional protocols, and rapid intervention during acute decompensation.

---

Peptic Ulcer Disease (PUD) & Gastrointestinal Hemorrhage

Peptic ulcer disease (PUD) involves mucosal ulceration extending through the muscularis mucosae into the deeper layers of the gastrointestinal wall, primarily affecting the stomach and proximal duodenum. Ulcerogenesis results from an imbalance between aggressive luminal factors (hydrochloric acid, pepsin, Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs [NSAIDs], ethanol, and physiological stress) and protective mucosal defenses (mucus-bicarbonate barrier, mucosal blood flow, epithelial cellular regeneration, and endogenous prostaglandins).

Gastric vs. Duodenal Ulcers: Clinical Differentiation

Helicobacter pylori Eradication Protocols

Helicobacter pylori is a spiral, microaerophilic gram-negative bacterium colonizing the gastric antrum that synthesizes urease, hydrolyzing gastric urea into ammonia and carbon dioxide to neutralize local acidity. Eradication is essential to prevent recurrent ulceration.

• First-Line Triple Therapy (14-Day Regimen):
  • Standard-dose Proton Pump Inhibitor (PPI) (e.g., Pantoprazole 40 mg PO BID or Esomeprazole 40 mg PO BID)
  • Clarithromycin 500 mg PO BID
  • Amoxicillin 1,000 mg PO BID (substitute Metronidazole 500 mg PO TID if penicillin allergy is documented)
• Bismuth Quadruple Therapy (14-Day Regimen - Preferred with High Macrolide Resistance):
  • Standard-dose PPI twice daily
  • Bismuth subsalicylate 300 mg PO QID
  • Metronidazole 500 mg PO TID or QID
  • Tetracycline 500 mg PO QID
• Patient Education: Inform patients that bismuth compounds cause harmless temporary black discoloration of the stool and tongue. Stress complete 14-day compliance to prevent antibiotic resistance.

Life-Threatening PUD Complications

1. Acute Perforation

Perforation occurs when an ulcer erodes through the full thickness of the gastric or duodenal wall, allowing caustic gastric and pancreatic juices, bile, and food particles to spill directly into the peritoneal cavity.

• Clinical Presentation: Sudden, abrupt onset of excruciating, severe, sharp epigastric pain that rapidly spreads across the entire abdomen and radiates to the right shoulder (phrenic nerve irritation). On physical examination, the abdomen exhibits rigid, board-like muscular guarding, extreme rebound tenderness, and complete absence of bowel sounds (paralytic ileus).
• Diagnostic Confirmation: Upright chest radiograph or plain abdominal X-ray revealing free air beneath the right hemidiaphragm (pneumoperitoneum).
• Immediate Nursing Actions:
  1. Place patient on strict NPO status immediately.
  2. Insert a large-bore nasogastric (NG) tube and connect to continuous low suction to decompress the stomach and prevent further spillage into the peritoneal space.
  3. Initiate aggressive IV crystalloid resuscitation (Lactated Ringer's or 0.9% Normal Saline) via two large-bore IV cannulas (16- to 18-gauge) to treat chemical peritonitis and impending hypovolemic shock.
  4. Administer prescribed broad-spectrum IV antibiotics and IV proton pump inhibitors.
  5. Prepare the patient for emergency exploratory laparotomy and surgical repair (Graham patch omentopexy).

2. Upper Gastrointestinal Hemorrhage

Erosion into an underlying arterial vessel (e.g., gastroduodenal artery in posterior duodenal ulcers) precipitates massive hemorrhage.

• Assessment: Frank hematemesis (bright red blood indicating rapid, active upper GI arterial hemorrhage), "coffee-ground" emesis (blood altered by gastric acid), melena (black, tarry, foul-smelling stools from oxidized heme), or hematochezia (maroon/bright red blood per rectum during massive, rapid bleeding exceeding 1,000 mL with accelerated transit).
• Hemodynamic Signs of Shock: Resting tachycardia (heart rate > 100 bpm), orthostatic hypotension (systolic BP drop >= 20 mmHg or diastolic drop >= 10 mmHg with postural change), progressing to recumbent hypotension, tachypnea, oliguria (< 30 mL/hr), diaphoresis, and altered mental status.
• Emergency Nursing Interventions:
  • Maintain airway and place patient in semi-Fowler position (or lateral recovery position if vomiting to prevent pulmonary aspiration).
  • Establish two large-gauge (16- or 18-gauge) peripheral IV lines.
  • Administer rapid isotonic crystalloids; obtain stat Type and Crossmatch for packed red blood cells (PRBCs).
  • Administer high-dose IV Proton Pump Inhibitor therapy (e.g., Pantoprazole 80 mg IV bolus followed by 8 mg/hr continuous infusion) to suppress acid secretion, maintaining intragastric pH > 6.0 to stabilize clot formation.
  • Prepare for urgent Esophagogastroduodenoscopy (EGD) within 24 hours for diagnostic visualization and endoscopic hemostasis (epinephrine injection, thermal coagulation, hemoclips).

---

Acute Pancreatitis: Pathophysiology & Critical Nursing Management

Acute pancreatitis is an acute inflammatory process of the pancreas characterized by premature intracellular activation of pancreatic zymogens (digestive proenzymes) within acinar cells. Instead of activating harmlessly in the duodenal lumen, trypsinogen converts to active trypsin, which subsequently activates elastase, phospholipase A2, and carboxypeptidases. This cascade triggers autodigestion of the pancreatic parenchymal tissue, breakdown of cell membranes, microvascular damage, hemorrhage, and extensive retroperitoneal fat necrosis.

Primary Etiologies

• Gallstones / Biliary Tract Disease (40% to 50%): Gallstones migrating down the common bile duct lodge transiently in the ampulla of Vater, creating ampullary reflux or pancreatic ductal hypertension.
• Chronic Ethanol Abuse (30% to 40%): Alcohol induces direct acinar toxicity, promotes intraductal protein plug formation, and causes spasm of the sphincter of Oddi.
• Other Causes (mnemonic 'I GET SMASHED'): Idiopathic, Gallstones, Ethanol, Trauma, Steroids, Mumps/viral infections, Autoimmune, Scorpion venom, Hypertriglyceridemia (serum triglycerides > 1,000 mg/dL), Hypercalcemia, ERCP (post-procedure complication), Drugs (azathioprine, thiazides, furosemide, valproic acid).

Clinical Presentation & Diagnostic Hallmarks

• Abdominal Pain: Severe, unremitting, agonizing epigastric and periumbilical pain radiating straight through to the back (frequently described as a boring sensation). The pain intensifies in the supine position and is partially relieved by sitting upright and leaning forward or assuming a fetal/knee-chest position. Associated with persistent nausea, vomiting that does not relieve the pain, and paralytic ileus.
• Physical Signs of Retroperitoneal Hemorrhagic Pancreatitis:
  • Cullen's Sign: Faint, bluish-purple periumbilical ecchymosis resulting from the tracking of retroperitoneal hemoperitoneum along the falciform ligament to the subcutaneous umbilical tissue.
  • Grey Turner's Sign: Bluish-brown discoloration along the bilateral flanks reflecting retroperitoneal hemorrhage dissecting along tissue planes.
• Laboratory Diagnostics:
  • Serum Lipase: The gold standard diagnostic enzyme. Lipase rises within 4 to 8 hours, peaks at 24 hours, and remains elevated for 8 to 14 days. Serum lipase levels greater than 3 times the upper reference limit are highly sensitive and specific for acute pancreatitis.
  • Serum Amylase: Rises rapidly (within 2 to 12 hours) but normalizes quickly within 3 to 5 days; less specific than lipase.
  • Leukocytosis: WBC > 16,000/mm³ reflecting systemic inflammation.
  • Elevated Hematocrit: Hemoconcentration (Hct > 44%) reflects massive third-space capillary leak into retroperitoneal and peritoneal spaces, signaling severe intravascular volume depletion.

Hypocalcemia in Acute Pancreatitis

Hypocalcemia occurs as lipases break down retroperitoneal mesenteric fat into free fatty acids, which avidly bind ionized calcium to form insoluble calcium soaps—a chemical process termed fat saponification.

• Clinical Signs of Latent Tetany:
  • Chvostek's Sign: Lightly tapping the facial nerve anterior to the external auditory meatus produces involuntary ipsilateral twitching of the facial muscles (twitching of the mouth, nose, or eye).
  • Trousseau's Sign: Inflating a blood pressure cuff on the upper arm to 20 mmHg above the patient's systolic pressure for 3 minutes induces carpal spasm (flexion of the wrist, thumb adduction, hyperextension of fingers) due to heightened peripheral neuromuscular excitability.
• Diagnostic & Nursing Care: Continuous cardiac telemetry to detect prolonged QT intervals (predisposing to torsades de pointes). Keep emergency IV Calcium Gluconate (10%) readily accessible at the bedside.

Evidence-Based Nursing & Medical Interventions

1. Strict NPO Status: Withhold all oral intake to completely rest the exocrine pancreas, halting the cephalic and gastric phases of secretion and eliminating secretin and cholecystokinin release.
2. Aggressive IV Fluid Resuscitation: Pancreatitis causes massive capillary permeability and third-space fluid sequestration. Administer balanced crystalloids (Lactated Ringer's solution preferred over normal saline to avoid hyperchloremic metabolic acidosis) at initial rates of 200 to 500 mL/hr, or 20 mL/kg bolus followed by 3 mL/kg/hr, titrating to maintain a mean arterial pressure >= 65 mmHg and urine output >= 0.5 to 1.0 mL/kg/hr.
3. Analgesic Management: Multimodal intravenous analgesia with hydromorphone or fentanyl. Historically, morphine was cautioned due to theoretical sphincter of Oddi spasm, but clinical evidence confirms opioids provide safe, effective pain relief without worsening clinical outcomes.
4. Nasogastric (NG) Tube Decompression: Indicated for severe intractable vomiting, significant abdominal distension, or paralytic ileus to reduce gastric distension and prevent pulmonary aspiration.
5. Nutritional Progression: As pain subsides, bowel sounds return, and inflammatory markers improve, reintroduce enteral nutrition. Enteral feeding (via nasojejunal tube placed distal to the ligament of Treitz) is strongly preferred over parenteral nutrition because it preserves the intestinal mucosal barrier and prevents bacterial translocation.

---

Liver Cirrhosis & Portal Hypertension Complications

Cirrhosis is the end-stage consequence of chronic hepatic parenchymal injury characterized by diffuse cellular necrosis, extensive collagen deposition and fibrous tissue bridging, and regenerative nodular architectural distortion. Fibrotic scarring obliterates sinusoidal vascular beds, creating heightened vascular resistance to portal blood flow entering from the mesenteric and splenic veins. Normal portal venous pressure (5 to 10 mmHg) rises pathologically to >= 10 to 12 mmHg, establishing Portal Hypertension and generating extensive portosystemic collateral vessels.

1. Ascites Management & Paracentesis Protocol

Ascites is the pathological accumulation of protein-containing serous fluid within the peritoneal cavity. It arises from the interplay of portal hypertension (increased hydrostatic pressure), hypoalbuminemia due to impaired hepatic synthetic function (decreased plasma oncotic pressure), and splanchnic arterial vasodilation triggering systemic RAAS activation and intense renal sodium and water retention.

• Medical Therapy: Strict dietary sodium restriction (< 2,000 mg/day). Combined diuretic therapy utilizing the aldosterone antagonist Spironolactone (100 mg/day) paired with the loop diuretic Furosemide (40 mg/day). This 100:40 mg ratio maintains physiological potassium balance while achieving effective natriuresis (titrated to maximum 400 mg spironolactone and 160 mg furosemide daily). The goal is a maximum daily weight loss of 0.5 kg/day (or 1.0 kg/day if peripheral edema is present) to avoid intravascular dehydration and renal impairment.
• Therapeutic Large-Volume Paracentesis Nursing Care:
  • Pre-procedure: Ensure informed consent is signed. Have the patient void immediately prior to the procedure to empty the bladder and prevent accidental bladder trocar perforation. Position patient in high-Fowler or semi-Fowler position. Obtain baseline vital signs, body weight, and abdominal girth at the level of the umbilicus.
  • Post-procedure Monitoring: Monitor vital signs every 15 minutes for the first hour to detect paracentesis-induced circulatory dysfunction (PICD) and hypovolemic shock. Apply a sterile pressure dressing over the puncture site and check for persistent fluid leakage.
  • Colloid Replacement Standard: For large-volume paracentesis exceeding 5 liters, administer IV 20% or 25% Albumin at a dose of 6 to 8 grams per liter of ascites fluid removed. Albumin expands intravascular oncotic pressure, preventing post-paracentesis arterial hypotension, hyponatremia, and hepatorenal syndrome.

2. Bleeding Esophageal Varices: Acute Emergency Care

Elevated portal venous pressure forces blood backward into submucosal venous plexuses of the lower esophagus and gastric fundus, producing thin-walled, tortuous, friable varices prone to spontaneous rupture with massive hemorrhage.

• Emergency Resuscitation: Maintain a patent airway (endotracheal intubation is indicated for active hematemesis or altered mental status to prevent aspiration). Establish two large-bore IVs. Administer packed red blood cells conservatively, maintaining a restrictive transfusion strategy with a target Hemoglobin of 7.0 to 8.0 g/dL; over-transfusion elevates central and portal pressures, triggering recurrent variceal rebleeding.
• Vasoactive Pharmacotherapy: Administer IV Octreotide (somatostatin analog) as a 50 mcg IV bolus followed immediately by a continuous IV infusion of 50 mcg/hr for 3 to 5 days. Octreotide causes selective splanchnic vasoconstriction, significantly decreasing portal inflow and variceal pressure.
• Endoscopic Hemostasis: Urgent EGD within 12 hours for Endoscopic Variceal Ligation (EVL / banding). Sclerotherapy is reserved when banding is technically unfeasible.
• Balloon Tamponade (Sengstaken-Blakemore / Minnesota Tube):
  • Employed as a temporary rescue bridge when massive variceal hemorrhage cannot be controlled endoscopically.
  • The Sengstaken-Blakemore tube possesses three lumens: gastric aspiration lumen, gastric balloon inflation lumen (inflated with 250 to 300 mL of air and secured with external traction), and esophageal balloon inflation lumen (inflated to 20 to 45 mmHg to compress bleeding esophageal veins).
  • CRITICAL NURSING SAFETY PROTOCOL: The nurse must maintain a pair of scissors at the patient's bedside at all times. If the gastric balloon deflates, ruptures, or slips upward into the oropharynx, the inflated esophageal balloon will migrate into the posterior pharynx, completely occluding the patient's airway and causing immediate asphyxiation. In the event of acute respiratory distress or airway obstruction, the nurse must immediately cut across all lumens of the tube with the bedside scissors to rapidly deflate all balloons, and immediately pull the tube out.
• Secondary Prophylaxis: Initiation of non-selective beta-blockers (Propranolol or Nadolol) once stabilized, titrated to reduce resting heart rate to 55 to 60 bpm, combined with serial EVL until varices are completely obliterated.

3. Hepatic Encephalopathy (HE)

Hepatic encephalopathy is a spectrum of reversible neuropsychiatric abnormalities occurring in cirrhosis. Portosystemic collateral shunting and hepatocellular dysfunction prevent the liver from detoxifying gut-derived neurotoxins, predominantly ammonia ($NH_3$) generated by bacterial deamination of dietary amino acids and urea in the colon. Free ammonia crosses the blood-brain barrier into cerebral astrocytes, where it is converted into glutamine by glutamine synthetase. Intracellular glutamine accumulation creates a hyperosmotic state, causing astrocyte swelling, cerebral edema, neuroinflammation, and impaired GABAergic and glutamatergic neurotransmission.

Clinical Manifestations & Staging (West Haven Criteria)

• Grade 1: Inverted sleep-wake cycle, mild confusion, euphoria or depression, subtle slurred speech, impaired calculation.
• Grade 2: Lethargy, moderate disorientation to time, inappropriate behavior, obvious Asterixis.
• Grade 3: Somnolence to semi-stupor, responsive to verbal stimuli, marked disorientation to time and place, bizarre behavior, muscular rigidity, hyperreflexia.
• Grade 4: Comatose state; non-responsive to verbal stimuli; decerebrate or decorticate posturing.
• Hallmark Physical Signs:
  • Asterixis ("Flapping Tremor"): Assessed by having the patient extend both arms forward with elbows locked, wrists dorsiflexed, and fingers spread apart. The patient exhibits involuntary, rapid, irregular rhythmic downward jerking movements of the hands due to transient lapses in motor muscle tone.
  • Fetor Hepaticus: A distinctive sweet, musty, fecal breath odor caused by the pulmonary excretion of volatile dimethyl sulfide and mercaptans.

Precipitating Triggers

Infection (spontaneous bacterial peritonitis, UTI), gastrointestinal hemorrhage (blood breakdown in gut delivers a massive protein surge), hypokalemia and metabolic alkalosis (alkalemia promotes conversion of ammonium $NH_4^+$ into diffusible ammonia $NH_3$), dehydration, constipation, and central nervous system sedatives.

Pharmacotherapy & Nursing Interventions

• Lactulose (First-Line Therapy): Synthetic non-absorbable disaccharide. In the colon, gut flora ferment lactulose into organic acids (lactic, acetic, and formic acids), lowering colonic luminal pH to approximately 5.0. In this acidic environment, diffusible ammonia ($NH_3$) accepts a hydrogen ion and converts into charged ammonium ($NH_4^+$) ("ammonia trapping"), which cannot permeate the bowel mucosa and is excreted in stool. Lactulose also exerts an osmotic laxative action.
  • Dosing Goal: Administer 20 to 30 g (30 to 45 mL) orally 2 to 4 times daily, titrated specifically to achieve 2 to 3 soft, semi-formed bowel movements per day. Overdosing causes excessive watery diarrhea, profound dehydration, and electrolyte disturbances (hypokalemia and hypernatremia).
  • Retention Enema: In comatose or vomiting patients, administer 300 mL lactulose diluted in 700 mL water via retention enema retained for 30 to 60 minutes.
• Rifaximin (Second-Line / Adjunctive): Oral non-absorbable rifamycin antibiotic (550 mg PO BID) that selectively eradicates ammonia-producing colonic bacteria without systemic absorption, used as add-on therapy with lactulose.
• Dietary Considerations: Maintain adequate dietary protein intake (1.2 to 1.5 g/kg/day). Severe protein restriction is outdated and contraindicated; it precipitates skeletal muscle breakdown, worsening encephalopathy because skeletal muscle serves as a vital secondary site for temporary ammonia detoxification.

---

Clinical Nutrition Support: Enteral vs. Parenteral Modalities

When oral caloric intake is insufficient or clinically contraindicated, enteral nutrition (EN) or total parenteral nutrition (TPN) is initiated to prevent protein-calorie malnutrition, preserve immunocompetence, and promote tissue repair.

Enteral Tube Feeding (NG / PEG / PEJ)

Enteral feeding is indicated when the patient has a functioning gastrointestinal tract but cannot safely ingest oral nutrition (e.g., severe dysphagia following stroke, head and neck surgery, prolonged mechanical ventilation).

Enteral Nutrition Safety Checklist:
1. Initial Verification: Abdominal X-ray is the GOLD STANDARD before any infusion.
2. Bedside pH Check: Gastric aspirate pH < 5.0 indicates gastric acidity.
3. Aspiration Prevention: HOB elevated ≥ 30 to 45 degrees during and 30-60 min post-feed.
4. Gastric Residuals: Check q4-6h; evaluate tolerance if GRV > 250-500 mL.
5. Water Flushing: 30 mL flush q4h, before/after feeds and meds; 5-10 mL between meds.

• Tube Placement Verification: An abdominal X-ray is the definitive gold standard to confirm the anatomical position of the tube tip before administering initial feedings, fluids, or medications. Auscultation of an injected air bolus over the epigastrium (the "whoosh" test) is unreliable and condemned by safety guidelines. For ongoing maintenance, measure and document the external tube length markings at the nares and test the pH of aspirated fluid (gastric aspirate pH is typically <= 5.0; intestinal aspirate pH >= 6.0; respiratory secretions pH >= 7.0).
• Aspiration Prevention Protocol: Maintain the Head of Bed (HOB) elevated to 30 to 45 degrees at all times during continuous feeding and for at least 30 to 60 minutes following intermittent bolus feedings. If the patient must be placed flat for repositioning or linen changes, pause the infusion temporarily.
• Gastric Residual Volume (GRV) Management: Assess GRV every 4 to 6 hours in continuously fed patients or immediately prior to each intermittent feed. While current critical care guidelines avoid automatically holding feeds for moderate residuals, a GRV between 250 and 500 mL warrants careful clinical evaluation for intolerance (abdominal distension, nausea, absent bowel sounds). Return aspirated residual to the stomach to avoid electrolyte imbalance and metabolic alkalosis unless volume exceeds 500 mL.
• Water Flushing Requirements: Flush feeding tubes with 30 mL of water every 4 hours during continuous feedings, before and after each intermittent bolus feeding, and before and after medication administration. Flush with 5 to 10 mL of water between individual medications. Never crush enteric-coated, sublingual, or sustained-release formulations.

Total Parenteral Nutrition (TPN) & Peripheral Parenteral Nutrition (PPN)

Parenteral nutrition provides intravenous hypertonic dextrose, amino acids, electrolytes, vitamins, minerals, and lipid emulsions directly into the vascular system, indicated exclusively when the gastrointestinal tract is non-functional or inaccessible (e.g., severe short bowel syndrome, high-output enterocutaneous fistulas, intractable paralytic ileus, severe acute necrotizing pancreatitis).

Critical TPN Nursing Safeguards

• Dedicated Line / Lumen: TPN must be infused through a strictly dedicated central venous lumen. Never piggyback blood products, IV antibiotics, or other intravenous medications into the TPN line due to severe chemical incompatibility and precipitation risks.
• Glycemic Surveillance: High dextrose concentrations provoke endogenous insulin release. Monitor capillary blood glucose levels every 4 to 6 hours, administering sliding-scale regular insulin as prescribed to maintain glycemic targets (140 to 180 mg/dL).
• Prevention of Rebound Hypoglycemia: TPN infusions must never be abruptly discontinued. The rate must be tapered downward gradually over several hours. CRITICAL EMERGENCY ACTION: If an ongoing TPN infusion bag runs dry or is interrupted unexpectedly and a replacement bag is not immediately available from the pharmacy, immediately hang an infusion of 10% Dextrose in Water (D10W) at the same infusion rate as the TPN. Abrupt cessation leaves circulating insulin unopposed, precipitating severe, life-threatening rebound hypoglycemia.
• Infection Control & Line Care: The hypertonic glucose and amino acid formulation provides an optimal growth medium for fungal (Candida albicans) and bacterial (Staphylococcus aureus) pathogens. Change the TPN solution bag and IV administration tubing every 24 hours using strict aseptic technique. Change lipid emulsion tubing every 12 to 24 hours. Assess CVAD dressing daily; perform chlorhexidine skin antisepsis during weekly sterile dressing changes.
• Refeeding Syndrome Vigilance: Occurs in severely malnourished patients receiving sudden carbohydrate loads. Insulin secretion drives electrolytes into cells, producing profound hypophosphatemia (the hallmark), hypokalemia, and hypomagnesemia, leading to cardiac dysrhythmias, respiratory failure, and paresthesias. Check baseline electrolyte panels prior to initiating TPN and advance caloric infusion rates gradually.